Turing Rejects $100 Million Offer For Daraprim
May 10, 2017 at 11:32 AM EDT
Let’s talk Daraprim — again. The controversially pricey drug that set regulators on their toes and prompted critical ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.